Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)

CAPS Rating: 5 out of 5

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants.

Recs

0
Player Avatar BillyTG (91.70) Submitted: 10/21/2010 10:50:32 AM : Outperform Start Price: $2.91 IDRA Score: -76.71

rfaramir follow on zzlangerhan's follow on portefeuille's rec of his rec

Report this Post 1 Comment
Member Avatar rfaramir (98.12) Submitted: 10/21/2010 3:07:46 PM
Recs: 1

LOL!
I gotta warn you, that's a pretty weak reasoning chain for a rec, at least my part of it.

Featured Broker Partners


Advertisement